Novo Nordisk a/s
Novo Nordisk A/S is the parent of the Novo Nordisk group, a global healthcare company.
AI Overview
With $30K in lobbying spend across 8 quarterly filings, Novo Nordisk a/s is an active lobbying client. Their lobbying covers 2 issue areas. Active from 2024 to 2025.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2024 | $30K |
| 2025 | $0 |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Novo Nordisk a/s disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Manufacturing
Manufacturing capacity and supply chain resiliency.
Issues related to manufacturing capacity and supply chain resiliency.
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.